These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6692648)

  • 1. Intraperitoneal and intravenous cefoperazone kinetics during continuous ambulatory peritoneal dialysis.
    Keller E; Jansen A; Pelz K; Hoppe-Seyler G; Schollmeyer P
    Clin Pharmacol Ther; 1984 Feb; 35(2):208-13. PubMed ID: 6692648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis.
    Somani P; Shapiro RS; Stockard H; Higgins JT
    Clin Pharmacol Ther; 1982 Jul; 32(1):113-21. PubMed ID: 7083725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis.
    Gross ML; Somani P; Ribner BS; Raeader R; Freimer EH; Higgins JT
    Clin Pharmacol Ther; 1983 Nov; 34(5):673-80. PubMed ID: 6313276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis.
    Johnson CA; Zimmerman SW; Reitberg DP; Whall TJ; Leggett JE; Craig WA
    Antimicrob Agents Chemother; 1988 Jan; 32(1):51-6. PubMed ID: 3348613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
    Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
    Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin kinetics during continuous ambulatory peritoneal dialysis.
    Bunke CM; Aronoff GR; Brier ME; Sloan RS; Luft FC
    Clin Pharmacol Ther; 1983 Nov; 34(5):631-7. PubMed ID: 6627823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
    Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
    Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxalactam epimer disposition in patients undergoing continuous ambulatory peritoneal dialysis.
    Morse G; Janicke D; Cafarell R; Piontek K; Apicella M; Jusko WJ; Walshe J
    Clin Pharmacol Ther; 1985 Aug; 38(2):150-6. PubMed ID: 4017417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis.
    Bouchet JL; Albin H; Quentin C; de Barbeyrac B; Vinçon G; Martin-Dupont P; Potaux L; Aparicio M
    Clin Nephrol; 1988 Jan; 29(1):35-40. PubMed ID: 3383462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Petersen J; Stewart RD; Catto GR; Edward N
    Nephron; 1985; 40(1):79-82. PubMed ID: 4000338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis.
    Johnson CA; Zimmerman SW; Bayer W; Craig WA
    Clin Nephrol; 1985 Mar; 23(3):120-4. PubMed ID: 3857136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ampicillin and sulbactam pharmacokinetics and pharmacodynamics in continuous ambulatory peritoneal dialysis (CAPD).
    Blackwell BG; Leggett JE; Johnson CA; Zimmerman SW; Craig WA
    Perit Dial Int; 1990; 10(3):221-6. PubMed ID: 2099158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefoperazone in patients undergoing chronic ambulatory peritoneal dialysis: clinical and pathophysiological implications.
    Hodler JE; Galeazzi RL; Frey B; Rudhardt M; Seiler AJ
    Eur J Clin Pharmacol; 1984; 26(5):609-12. PubMed ID: 6468477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of piperacillin during continuous ambulatory peritoneal dialysis].
    Ryckelynck JP; Debruyne D; Hurault De Ligny B; Moulin M
    Pathol Biol (Paris); 1988 May; 36(5):507-10. PubMed ID: 3043348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxalactam kinetics during chronic ambulatory peritoneal dialysis.
    Singlas E; Boutron HF; Merdjan H; Brocard JF; Pocheville M; Fries D
    Clin Pharmacol Ther; 1983 Sep; 34(3):403-7. PubMed ID: 6224624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis.
    Bunke CM; Aronoff GR; Brier ME; Sloan RS; Luft FC
    Clin Pharmacol Ther; 1983 Jan; 33(1):66-72. PubMed ID: 6848301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.